Truxima is a prescription drug used to treat certain blood cancers and rheumatoid arthritis. It can cause side effects ranging from mild (such as nausea and fatigue) to serious, including kidney ...

Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...

Truxima is a biosimilar version of the brand-name drug Rituxan. Biosimilars tend to be less expensive than their brand-name versions. Doctors prescribe Truxima to treat conditions such as rheumatoid ...

Primary Mediastinal Large B-Cell Lymphoma: A Clinicopathologic Study of 43 Patients From the Nebraska Lymphoma Study Group PURPOSE: Rituximab was recently approved for use in relapsed, low-grade ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rituximab and ocrelizumab appeared to increase risk for ...

Pediatric patients receiving a combination of rituximab and cyclophosphamide therapy for rheumatic disease showed clinical improvement with a low risk for adverse effects. While current clinical ...

In a new phase 3, double-blind study, researchers explored the efficacy and safety of combination therapy using subcutaneous (SC) belimumab and rituximab for the treatment of active systemic lupus ...

The FDA approval of Rituxan plus chemotherapy is indicated for the treatment of children aged six months to 18 years who have various forms of lymphoma or a form of leukemia. The Food and Drug ...

These data indicate that either alternative vaccine strategies or alternative strategies to protect these patients from pneumococcal disease are required,’ said Michael Chen-Xu, MD.

Truxima (rituximab-abbs) is a brand-name drug that’s prescribed for certain blood cancers, rheumatoid arthritis, and other conditions in adults. As with other drugs, Truxima can cause side effects, ...